Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver

Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver

Yanan Feng,1,&ast; Wenxiu Sun,2,&ast; Fengcui Sun,1 Guoliang Yin,1 Pengpeng Liang,1 Suwen Chen,1 Xiangyi Liu,1 Tongfei Jiang,3 Fengxia Zhang4 1Shandong University of Traditional Chinese Medicine, Jinan, 250000, People’s Republic of China; 2Department of Nursing, Taishan Vocational College of...

Full description

Bibliographic Details
Main Authors:	Feng Y, Sun W, Sun F, Yin G, Liang P, Chen S, Liu X, Jiang T, Zhang F
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-11-01
Series:	Drug Design, Development and Therapy
Subjects:	nafld cd36 natural inhibitors ffa tg
Online Access:	https://www.dovepress.com/biological-mechanisms-and-related-natural-inhibitors-of-cd36-in-nonalc-peer-reviewed-fulltext-article-DDDT

Similar Items

Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver
by: Meng D, et al.
Published: (2023-12-01)

SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism
by: Jiangxue Han, et al.
Published: (2023-06-01)

Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
by: Esther Rey, et al.
Published: (2020-08-01)

Chitooligosaccharide supplementation prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36)
by: Mengyao Zhao, et al.
Published: (2019-06-01)

CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
by: Han Zeng, et al.
Published: (2022-03-01)

Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis
by: Mengyue You, et al.
Published: (2022-11-01)

The polymorphism analysis for CD36 among platelet donors
by: Qilu Lyu, et al.
Published: (2024-04-01)

Role of Corticosterone in Lipid Metabolism in Broiler Chick White Adipose Tissue
by: Kazuhisa Honda, et al.
Published: (2022-04-01)

Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study
by: Rennan Feng, et al.
Published: (2017-09-01)

Lymphocytes upregulate CD36 in adipose tissue and liver
by: Jacob Couturier, et al.
Published: (2019-01-01)

Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research
by: Zekai Chen, et al.
Published: (2019-08-01)

Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults
by: Shuying Li, et al.
Published: (2023-11-01)

Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China
by: Qilu Lyu, et al.
Published: (2023-12-01)

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163
by: Maria Kløjgaard Skytthe, et al.
Published: (2023-01-01)

<i>Brassica oleracea</i> Var <i>italica</i> by-Products Prevent Lipid Accumulation and Cell Death in a Liver Cell Model of Lipid Toxicity
by: José P. Castelão-Baptista, et al.
Published: (2023-02-01)

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
by: Christian Baumeier, et al.
Published: (2017-10-01)

CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
by: Noorzaileen Eileena Zaidi, et al.
Published: (2022-11-01)

SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
by: Hannah Åbacka, et al.
Published: (2024-04-01)

Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
by: Cristiana Tanase, et al.
Published: (2022-01-01)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01)

Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways
by: Ira J. Goldberg, et al.
Published: (2009-01-01)

Interaction between sarcopenia and nonalcoholic fatty liver disease
by: Sae Kyung Joo, et al.
Published: (2023-02-01)

How Arrestins and GRKs Regulate the Function of Long Chain Fatty Acid Receptors
by: Abdulrahman G. Alharbi, et al.
Published: (2022-10-01)

The Exocyst Is Required for CD36 Fatty Acid Translocase Trafficking and Free Fatty Acid Uptake in Skeletal Muscle Cells
by: Nicole K. Nakamura, et al.
Published: (2022-08-01)

Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
by: Chiang-Chi Huang, et al.
Published: (2021-11-01)

CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease
by: Mona A. Amin, et al.
Published: (2023-03-01)

Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population
by: Yicen Zong, et al.
Published: (2020-05-01)

CD36 deficiency ameliorates drug-induced acute liver injury in mice
by: Chen Zhang, et al.
Published: (2021-06-01)

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
by: Jinyun Bai, et al.
Published: (2020-07-01)

Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study
by: Ran Li, et al.
Published: (2023-02-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Selective transport of long-chain fatty acids by FAT/CD36 in skeletal muscle of broilers
by: J. Guo, et al.
Published: (2013-01-01)

Protective effect of SGL5213, a potent intestinal sodium–glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice
by: Yasushi Honda, et al.
Published: (2021-10-01)

Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD)
by: Rodolfo Quintana Castro, et al.
Published: (2018-06-01)

Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01)

MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice
by: Hung-Yu Lin, et al.
Published: (2019-10-01)

Adiponectin Enhances Fatty Acid Signaling in Human Taste Cells by Increasing Surface Expression of CD36
by: Fangjun Lin, et al.
Published: (2023-03-01)

Hypothalamic Fatty Acids and Ketone Bodies Sensing and Role of FAT/CD36 in the Regulation of Food Intake
by: Christelle Le Foll
Published: (2019-08-01)

Elevated Interleukin-36α And CD4+IL-36α+T Cells Are Involved in the Pathogenesis of Graves' Disease
by: Qiu-ming Yao, et al.
Published: (2018-10-01)